{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T15:57:23Z","timestamp":1648915043866},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1684\/bdc.2013.1713","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T19:58:43Z","timestamp":1565726323000},"page":"247-257","source":"Crossref","is-referenced-by-count":1,"title":["Traitement \u00e0 domicile par l\u2019acide zol\u00e9dronique chez des patients atteints de tumeurs solides : observance et satisfaction du patient et de l\u2019infirmier"],"prefix":"10.1016","volume":"100","author":[{"given":"Thierry","family":"Lebret","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Loup","family":"Mouysset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude El","family":"Kouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Bastit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meryem","family":"Ktiouet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slimane","family":"Khemaies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Murraciole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Gu\u00e9rif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2013.1713_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1749-6632.2010.05766.x","article-title":"The use of bisphosphonates in cancer treatment","volume":"1218","author":"Coleman","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1684\/bdc.2013.1713_bib0010","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-21892-7","article-title":"Prevention of bone metastases","volume":"192","author":"Joerger","year":"2012","journal-title":"Recent results in cancer research series"},{"key":"10.1684\/bdc.2013.1713_bib0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1684\/bdc.2011.1481","article-title":"Traitements des m\u00e9tastases osseuses du cancer","volume":"99","author":"Gligorov","year":"2012","journal-title":"Bull Cancer"},{"key":"10.1684\/bdc.2013.1713_bib0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cncr.25529","article-title":"Zoledronic acid use in cancer patients: more than just supportive care?","volume":"117","author":"Coleman","year":"2011","journal-title":"Cancer"},{"key":"10.1684\/bdc.2013.1713_bib0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/SPC.0b013e328349dc17","article-title":"Antitumor effects of bisphosphonates: from the laboratory to the clinic","volume":"5","author":"Berenson","year":"2011","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1684\/bdc.2013.1713_bib0030","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1586\/era.11.71","article-title":"Zoledronic acid: multiplicity of use across the cancer continuum","volume":"11","author":"Lipton","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1684\/bdc.2013.1713_bib0035","first-page":"CD003474","article-title":"Bisphosphonates and other bone agents for breast cancer","volume":"2","author":"Wong","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1684\/bdc.2013.1713_bib0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejca.2011.10.021","article-title":"The efficacy of zoledronic acid in breast cancer adjuvant therapy: a meta-analysis of randomised controlled trials","volume":"48","author":"Yan","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1684\/bdc.2013.1713_bib0045","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00520-004-0628-z","article-title":"Bisphosphonate infusions: patient preference, safety and clinic use","volume":"12","author":"Chern","year":"2004","journal-title":"Support Care Cancer"},{"key":"10.1684\/bdc.2013.1713_bib0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3747\/co.v17i2.507","article-title":"Feasibility of administering zoledronic acid in palliative patients being cared for in the community: results of a pilot study","volume":"17","author":"Marr","year":"2010","journal-title":"Curr Oncol"},{"key":"10.1684\/bdc.2013.1713_bib0055","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/sj.bjc.6602551","article-title":"Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration","volume":"92","author":"Wardley","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1684\/bdc.2013.1713_bib0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1179\/joc.2006.18.2.217","article-title":"Home infusions of biphosphonate in cancer patients: a prospective study","volume":"18","author":"Italiano","year":"2006","journal-title":"J Chemother"},{"key":"10.1684\/bdc.2013.1713_bib0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.archger.2005.10.006","article-title":"The use of bisphosphonates in palliative treatment of bone metastases in a terminally ill, oncological elderly population","volume":"43","author":"Santangelo","year":"2006","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1684\/bdc.2013.1713_bib0070","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1089\/jpm.2006.0122","article-title":"Zoledronic acid treatment at home: safety data from an observational prospective trial","volume":"10","author":"Tassinari","year":"2007","journal-title":"J Palliat Med"},{"key":"10.1684\/bdc.2013.1713_bib0075","first-page":"26","article-title":"R\u00f4le de l\u2019infirmi\u00e8re dans la prise en charge \u00e0 domicile des patients atteints de cancer du sein avec m\u00e9tastases osseuses","volume":"715","author":"Quesnel","year":"2007","journal-title":"Soins"},{"key":"10.1684\/bdc.2013.1713_bib0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1517\/14740338.2011.540387","article-title":"Zoledronic acid","volume":"10","author":"Coleman","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1684\/bdc.2013.1713_bib0085","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3899\/jrheum.100221","article-title":"Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons","volume":"38","author":"Khan","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1684\/bdc.2013.1713_bib0090","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1185\/030079907X210543","article-title":"An audit to determine the time taken to administer intravenous bisphosphonate infusions in patients diagnosed with metastatic breast cancer to bone in a hospital setting","volume":"23","author":"Barrett-Lee","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1684\/bdc.2013.1713_bib0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejon.2011.02.006","article-title":"Taking the lead: sharing best practice in intravenous bisphosphonate use in urological cancers","volume":"16","author":"Jensen","year":"2012","journal-title":"Eur J Oncol Nurs"},{"key":"10.1684\/bdc.2013.1713_bib0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ctrv.2012.07.002","article-title":"Denosumab in patients with cancer and skeletal metastases: a systematic review and meta-analysis","volume":"39","author":"Peddi","year":"2013","journal-title":"Cancer Treat Rev"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115302551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115302551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T08:26:38Z","timestamp":1602491198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115302551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0007455115302551"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2013.1713","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}